The marginal GLP-1 customer is recruited from the beauty aisle, not the clinic.
As payer coverage retrenches and medical obesity saturates, Novo and Lilly are rebranding patients as consumers — lifestyle campaigns, celebrity DTC ads, and $149 self-pay pricing — to recruit cosmetic users whom insurance will never cover.
The same conclusion keeps arriving from across the workspace's research — 1 topics independently instantiate this theme. Filter the evidence by where it came from:
Deliberate lifestyle repositioning recruits the look-and-feel-better self-pay segment while handing payers ammunition to keep the category classified as discretionary.
A celebrity DTC spot plus a cash-pay price cut is what actually inflected scripts, confirming that consumer marketing rather than clinical coverage now drives the marginal prescription.